Entera Bio
ENTX
12 hedge funds and large institutions have $416K invested in Entera Bio in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
6,650% more call options, than puts
Call options by funds: $135K | Put options by funds: $2K
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
33% more funds holding
Funds holding: 9 → 12 (+3)
5.6% less ownership
Funds ownership: 16.19% → 10.59% (-5.6%)
91% less capital invested
Capital invested by funds: $4.85M → $416K (-$4.44M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$85.6K |
| 2 |
Millennium Management
New York
|
+$26K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$22.1K |
| 4 |
HF
HRT Financial
New York
|
+$11K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$1.29M |
| 2 |
Morgan Stanley
New York
|
-$25.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RCM
1
RA Capital Management
Boston,
Massachusetts
| $216K | -$1.29M | -1,786,406 | -86% |
|
|
2
Renaissance Technologies
New York
| $102K | +$85.6K | +118,300 | +555% |
|
|
3
Millennium Management
New York
| $34K | +$26K | +35,968 | +359% |
|
|
4
Citadel Advisors
Miami,
Florida
| $22.2K | +$22.1K | +30,465 | New |
|
5
Geode Capital Management
Boston,
Massachusetts
| $12K | – | – | – |
|
|
HF
6
HRT Financial
New York
| $11K | +$11K | +15,236 | New |
|
|
7
UBS Group
Zurich,
Switzerland
| $7.58K | +$6.25K | +8,634 | +492% |
|
8
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $7.3K | – | – | – |
|
|
KCM
9
Knoll Capital Management
Miami,
Florida
| $2.58K | – | – | – |
|
|
10
Morgan Stanley
New York
| $730 | -$25.5K | -35,166 | -97% |
|
11
BlackRock
New York
| $365 | +$362 | +500 | New |
|
ENTX Hedge Fund Activity: Q4 2022 in Review
12 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q4 2022, worth a combined $416K — down 91% from $4.85M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ENTX positions and 0 closed out — a net gain of 3 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $85.6K. The largest seller was RA Capital Management, cutting an estimated $1.29M.
- 12 institutional investors held Entera Bio (ENTX) as of Q4 2022, up from 9 in Q3 2022.
- Funds reported $416K of Entera Bio stock for Q4 2022, down 91% quarter-over-quarter.
- 3 funds opened new Entera Bio positions in Q4 2022 and 0 closed out, a net change of +3 holders.
- The largest Entera Bio buyer in Q4 2022 was Renaissance Technologies, an estimated $85.6K added.
- The largest Entera Bio seller in Q4 2022 was RA Capital Management, an estimated $1.29M sold.
Based on aggregated 13F filings for Q4 2022.